Clinical Trials Directory

Trials / Completed

CompletedNCT02737215

Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea

Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea: a Multicenter Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Rodrigo Pinto Pedrosa · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Background. Atrial fibrillation is one of the most common complications in the postoperative period of coronary artery bypass grafting (CABG) surgery and usually associated with increased length of hospital stay and higher hospital costs. Among the main mechanisms involved, excessive sympathetic activation, oxidative stress and inflammation are fundamental elements in the pathophysiology of obstructive sleep apnea. Objectives. To evaluate the effects of continuous positive airway pressure (CPAP) in reduction of atrial fibrillation after CABG in patients with obstructive sleep apnea. Methodological procedures: A multicenter randomized controlled study to compare the incidence of atrial fibrillation between the intervention group and the control group, both monitored seven days with Holter.

Conditions

Interventions

TypeNameDescription
DEVICECPAPpatients will receive CPAP therapy with Auto-CPAP

Timeline

Start date
2016-05-02
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2016-04-13
Last updated
2021-12-09

Locations

3 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02737215. Inclusion in this directory is not an endorsement.